IDEAS home Printed from https://ideas.repec.org/a/abf/journl/v15y2019i1p11042-11051.html
   My bibliography  Save this article

FXYD Domain Containing Ion Transport Regulator 3 (FXYD3) is Over-Expressed in Germinal Centre Derived Aggressive Lymphomas and Plasma Cell Myeloma

Author

Listed:
  • Cristiano Peron
  • Axel Visani
  • Alessandra Weber
  • Flavia Rigotti

    (Department of Experimental, Diagnostic, and Specialty Medicine, Bologna University School of Medicine, Bologna, Italy)

  • Yonis Ahmed
  • Shaymaa Khattab
  • Ashraf El-Ghandour
  • Manal El-Sorady

    (Internal Medicine Department, Egypt)

  • Mohsen Navari

    (Department of Medical Biotechnology, School of Paramedical Sciences, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran
    Department of Medical Biotechnology, School of Paramedical Sciences, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran
    Bioinformatics Research Group, Mashhad University of Medical Sciences, Mashhad, Iran)

  • Giuseppe Visani

    (Hematology and Hematopoietic Stem Cell Transplant Center, AORMIN, Pesaro, Italy)

  • Pier Paolo Piccaluga

    (Department of Experimental, Diagnostic, and Specialty Medicine, Bologna University School of Medicine, Bologna, Italy
    Istituto Euro-Mediterraneo di Scienza e Tecnologia (IEMEST) Palermo, Italy
    Department of Pathology, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya)

Abstract

FXYD3 is a Na/K-ATPase regulator which has been recently associated with different cancers development and progression; consequently, FXYD3 has been proposed in those as a potential therapeutic target...

Suggested Citation

  • Cristiano Peron & Axel Visani & Alessandra Weber & Flavia Rigotti & Yonis Ahmed & Shaymaa Khattab & Ashraf El-Ghandour & Manal El-Sorady & Mohsen Navari & Giuseppe Visani & Pier Paolo Piccaluga, 2019. "FXYD Domain Containing Ion Transport Regulator 3 (FXYD3) is Over-Expressed in Germinal Centre Derived Aggressive Lymphomas and Plasma Cell Myeloma," Biomedical Journal of Scientific & Technical Research, Biomedical Research Network+, LLC, vol. 15(1), pages 11042-11051, February.
    • Handle: RePEc:abf:journl:v:15:y:2019:i:1:p:11042-11051
    DOI: 10.26717/BJSTR.2019.15.002635
    as

    Download full text from publisher

    File URL: https://biomedres.us/pdfs/BJSTR.MS.ID.002635.pdf
    Download Restriction: no
    File URL: https://biomedres.us/fulltexts/BJSTR.MS.ID.002635.php
    Download Restriction: no
    File URL: https://libkey.io/10.26717/BJSTR.2019.15.002635?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Keywords

    Biomedical Sciences; Biomedical Research; Technical Research; FXYD3; B-cell Lymphoma; Plasma Cell Myeloma; Survival; Gene Expression; Drug Resistance;
    All these keywords.

    JEL classification:

    • R00 - Urban, Rural, Regional, Real Estate, and Transportation Economics - - General - - - General
    • Z0 - Other Special Topics - - General

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:abf:journl:v:15:y:2019:i:1:p:11042-11051. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Angela Roy (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.